These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9041203

  • 1. Predominant cytosolic localization of type II transforming growth factor beta receptors in human breast carcinoma cells.
    Koli KM, Arteaga CL.
    Cancer Res; 1997 Mar 01; 57(5):970-7. PubMed ID: 9041203
    [Abstract] [Full Text] [Related]

  • 2. Expression of mRNA coding for TGF-beta and its receptors in irradiated human breast carcinoma MCF-7 cells differing in their sensitivity to doxorubicin.
    Chorna I, Fedorenko O, Datsyuk L, Stoika R.
    Exp Oncol; 2005 Jun 01; 27(2):156-8. PubMed ID: 15995636
    [Abstract] [Full Text] [Related]

  • 3. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y, Banerji SS, Liu Y, Li W, Liang J, Soule HD, Pauley RJ, Willson JK, Zborowska E, Brattain MG.
    J Cell Physiol; 1998 Aug 01; 176(2):424-34. PubMed ID: 9648930
    [Abstract] [Full Text] [Related]

  • 4. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
    Tsang KJ, Tsang D, Brown TN, Crowe DL.
    Anticancer Res; 2002 Aug 01; 22(1A):13-9. PubMed ID: 12017275
    [Abstract] [Full Text] [Related]

  • 5. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X, Bellis S, Yan Z, Friedman E.
    Cell Growth Differ; 1999 Jan 01; 10(1):11-8. PubMed ID: 9950213
    [Abstract] [Full Text] [Related]

  • 6. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
    Yang L, Yang J, Venkateswarlu S, Ko T, Brattain MG.
    J Cell Physiol; 2001 Sep 01; 188(3):383-93. PubMed ID: 11473365
    [Abstract] [Full Text] [Related]

  • 7. Transforming growth factor beta type II receptor expression in gastric cancer: evidence for two independent subgroups.
    Takeno S, Wirtz HC, Lickvers K, Noguchi T, Scheven M, Willers R, Gabbert HE, Mueller W.
    Anticancer Res; 2002 Sep 01; 22(4):2247-52. PubMed ID: 12174910
    [Abstract] [Full Text] [Related]

  • 8. Cell-cycle-dependent expression of transforming growth factor beta type I receptor correlates with differential proliferative effects of TGFbeta1 in articular chondrocytes.
    Boumediene K, Félisaz N, Pujol JP.
    Exp Cell Res; 1998 Aug 25; 243(1):173-84. PubMed ID: 9716461
    [Abstract] [Full Text] [Related]

  • 9. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
    Copland JA, Luxon BA, Ajani L, Maity T, Campagnaro E, Guo H, LeGrand SN, Tamboli P, Wood CG.
    Oncogene; 2003 Sep 11; 22(39):8053-62. PubMed ID: 12970754
    [Abstract] [Full Text] [Related]

  • 10. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
    Kubo M, Ihn H, Yamane K, Tamaki K.
    Br J Dermatol; 2006 May 11; 154(5):919-25. PubMed ID: 16634896
    [Abstract] [Full Text] [Related]

  • 11. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K, Yamashita H, Mogi A, Takenoshita S, Miyazono K.
    J Cell Physiol; 1998 Jun 11; 175(3):305-13. PubMed ID: 9572475
    [Abstract] [Full Text] [Related]

  • 12. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
    Park B, Jang JS, Park K.
    Int J Oncol; 2000 Sep 11; 17(3):473-8. PubMed ID: 10938386
    [Abstract] [Full Text] [Related]

  • 13. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A, Mincione G, Lazzereschi D, Ranieri A, Turco A, Lucignano B, Scarpa S, Ragano-Caracciolo M, Colletta G.
    J Cell Physiol; 1997 Aug 11; 172(2):200-8. PubMed ID: 9258341
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical localization of EGF, TGF-alpha, TGF-beta, and their receptors in rat corneas during healing of excimer laser ablation.
    Tuli SS, Liu R, Chen C, Blalock TD, Goldstein M, Schultz GS.
    Curr Eye Res; 2006 Sep 11; 31(9):709-19. PubMed ID: 16966143
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

  • 16. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, Varga J.
    Arthritis Rheum; 2004 Dec 15; 50(12):4008-21. PubMed ID: 15593186
    [Abstract] [Full Text] [Related]

  • 17. Vectorial TGFbeta signaling in polarized intestinal epithelial cells.
    Yakovich AJ, Huang Q, Du J, Jiang B, Barnard JA.
    J Cell Physiol; 2010 Aug 15; 224(2):398-404. PubMed ID: 20432436
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB, Moody TW, Mariano JM.
    Anticancer Res; 1997 Aug 15; 17(3C):1849-60. PubMed ID: 9216635
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y, Kyprianou N.
    Cell Growth Differ; 1998 Feb 15; 9(2):185-93. PubMed ID: 9486855
    [Abstract] [Full Text] [Related]

  • 20. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K, Su J, Trovitch PB.
    J Pharm Pharmacol; 2003 Aug 15; 55(8):1135-41. PubMed ID: 12956904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.